Reactive Oxygen Species-Responsive Microgels Loaded with Vascular Endothelial Growth Factor─Engineered Endothelial Extracellular Vesicles for Diabetic Wound Healing via Microenvironment Reprogramming
Source abstract
Abstract
Diabetic wound healing is hampered by a dysregulated pathological microenvironment characterized by excessive reactive oxygen species (ROS), persistent chronic inflammation, and impaired angiogenesis. To address these challenges, we developed an endogenously bioactive components-polymer matrix integration platform (P-MG@vEVs) via encapsulating vascular endothelial growth factor (VEGF)-stimulated endothelial extracellular vesicles (vEVs) into ROS-responsive microgels (P-MG). Endothelial cells were preconditioned with VEGF, and the resultant vEVs were isolated via differential centrifugation, with enhanced vesicle production and enriched angiogenic factors (e.g., VEGFA) that effectively promote endothelial cell migration and tube formation. P-MG@vEVs microgels composed of phenylboronic acid-modified sodium alginate were fabricated using microfluidic technology. Moreover, the microgels exhibited ROS-triggered degradation, enabling targeted and sustained vEVs release in the oxidative wound microenvironment. In vitro, P-MG@vEVs efficiently scavenged ROS, modulated macrophage polarization toward the anti-inflammatory M2 phenotype, and enhanced angiogenesis. In streptozotocin (STZ)-induced diabetic mice, P-MG@vEVs efficiently reprogrammed the damaged cutaneous microenvironment via regulating key signaling pathways (e.g., HIF-1, IL-17, NF-κB), thereby alleviating inflammation, restoring redox homeostasis, and facilitating neovascularization. These multifaceted effects significantly accelerate wound closure and skin repair, as evidenced by enhanced re-epithelialization and improved collagen deposition. Collectively, this platform integrates the intrinsic bioactivity of VEGF-preconditioned vEVs with the ROS-responsive delivery capability of the microgel carrier, offering a highly promising strategy for diabetic wound management.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Extracellular vesicles in disease · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Medicinal Chemical Biology, the Key Laboratory of Bioactive Materials, Ministry of Education
College of Life Science, Nankai University
Plastic Surgery Hospital
Chinese Academy of Medical Sciences and Peking Union Medical College
State Key Laboratory of Advanced Medical Materials and Devices, Institute of Biomedical Engineering
Funding
Chinese Academy of Medical Sciences Initiative for Innovative Medicine · National Natural Science Foundation of China (NSFC)
References (69)
Show source-provided references
1. 10.1038/s41578-024-00647-410.1038/s41578-024-00647-4 ↗
2. 10.1038/s41580-024-00715-110.1038/s41580-024-00715-1 ↗
3. 10.1093/burnst/tkad03510.1093/burnst/tkad035 ↗
4. 10.1126/scitranslmed.abn375810.1126/scitranslmed.abn3758 ↗
5. 10.1021/acsami.5c1624610.1021/acsami.5c16246 ↗
6. 10.1002/adma.20230629210.1002/adma.202306292 ↗
7. 10.1002/adfm.20231450010.1002/adfm.202314500 ↗
8. 10.1021/acsami.5c0540210.1021/acsami.5c05402 ↗
9. 10.1038/s41467-024-54075-710.1038/s41467-024-54075-7 ↗
10. 10.1002/adma.20250482910.1002/adma.202504829 ↗
11. 10.1002/adfm.20240048910.1002/adfm.202400489 ↗
12. 10.1016/j.bioactmat.2024.11.02910.1016/j.bioactmat.2024.11.029 ↗
13. 10.1021/acsami.5c0274310.1021/acsami.5c02743 ↗
14. 10.1002/advs.20241588610.1002/advs.202415886 ↗
15. 10.1016/j.bioactmat.2023.03.00510.1016/j.bioactmat.2023.03.005 ↗
16. 10.1002/adfm.20230771110.1002/adfm.202307711 ↗
17. 10.1126/sciadv.aaz801110.1126/sciadv.aaz8011 ↗
18. 10.1021/acsami.2c0859310.1021/acsami.2c08593 ↗
19. 10.1016/j.celbio.2025.10002010.1016/j.celbio.2025.100020 ↗
20. 10.1016/j.cell.2020.04.05410.1016/j.cell.2020.04.054 ↗
21. 10.1021/acsami.3c0363010.1021/acsami.3c03630 ↗
22. 10.1038/s41467-024-48284-310.1038/s41467-024-48284-3 ↗
23. 10.1016/j.cis.2019.01.00510.1016/j.cis.2019.01.005 ↗
24. 10.1016/j.bioactmat.2021.03.03810.1016/j.bioactmat.2021.03.038 ↗
25. 10.1002/adfm.20240525710.1002/adfm.202405257 ↗
26. 10.1016/j.cej.2025.16710810.1016/j.cej.2025.167108 ↗
27. 10.1002/adhm.20250006010.1002/adhm.202500060 ↗
28. 10.1002/smll.20230011110.1002/smll.202300111 ↗
29. 10.1016/j.jconrel.2025.11459410.1016/j.jconrel.2025.114594 ↗
30. 10.1002/advs.20230464110.1002/advs.202304641 ↗
31. 10.7150/thno.9733510.7150/thno.97335 ↗
32. 10.7150/thno.10277910.7150/thno.102779 ↗
33. 10.1002/smll.20251073310.1002/smll.202510733 ↗
34. 10.1016/j.bioactmat.2025.06.00410.1016/j.bioactmat.2025.06.004 ↗
35. 10.1016/j.cell.2019.01.02110.1016/j.cell.2019.01.021 ↗
36. 10.1038/nrm.2016.8710.1038/nrm.2016.87 ↗
37. 10.1002/advs.20240034910.1002/advs.202400349 ↗
38. 10.1093/cvr/cvs01710.1093/cvr/cvs017 ↗
39. 10.1021/acs.biomac.4c0084510.1021/acs.biomac.4c00845 ↗
40. 10.1016/j.bioactmat.2025.03.02510.1016/j.bioactmat.2025.03.025 ↗
41. 10.1016/j.cej.2025.16313010.1016/j.cej.2025.163130 ↗
42. 10.1002/advs.20250069610.1002/advs.202500696 ↗
43. 10.1021/acsnano.4c1729110.1021/acsnano.4c17291 ↗
44. 10.1186/s12951-025-03275-410.1186/s12951-025-03275-4 ↗
45. 10.1093/rb/rbaf00210.1093/rb/rbaf002 ↗
46. 10.1021/acs.biomac.6b0037810.1021/acs.biomac.6b00378 ↗
47. 10.1016/j.bioactmat.2025.07.00210.1016/j.bioactmat.2025.07.002 ↗
48. 10.1002/advs.20250643810.1002/advs.202506438 ↗
49. 10.1002/adfm.20250662310.1002/adfm.202506623 ↗
50. 10.1021/acsnano.4c1459610.1021/acsnano.4c14596 ↗
51. 10.1016/j.mattod.2024.01.00410.1016/j.mattod.2024.01.004 ↗
52. 10.1016/j.bioactmat.2024.07.00910.1016/j.bioactmat.2024.07.009 ↗
53. 10.1021/acsnano.1c0210210.1021/acsnano.1c02102 ↗
54. 10.1016/j.bioactmat.2022.06.01810.1016/j.bioactmat.2022.06.018 ↗
55. 10.1016/j.bioactmat.2024.12.01210.1016/j.bioactmat.2024.12.012 ↗
56. 10.1002/adfm.20231277210.1002/adfm.202312772 ↗
57. 10.1021/acsnano.4c1198610.1021/acsnano.4c11986 ↗
58. 10.1016/j.bioactmat.2024.01.00510.1016/j.bioactmat.2024.01.005 ↗
59. 10.1002/adma.20241780110.1002/adma.202417801 ↗
60. 10.1016/j.bioactmat.2025.08.01010.1016/j.bioactmat.2025.08.010 ↗
61. 10.1002/adfm.20250303510.1002/adfm.202503035 ↗
62. 10.1038/s41467-025-60858-310.1038/s41467-025-60858-3 ↗
63. 10.1002/adma.20241798010.1002/adma.202417980 ↗
64. 10.1016/j.bioactmat.2024.04.01910.1016/j.bioactmat.2024.04.019 ↗
65. 10.1016/j.bioactmat.2024.02.01010.1016/j.bioactmat.2024.02.010 ↗
66. 10.1038/s41392-022-01202-910.1038/s41392-022-01202-9 ↗
67. 10.1016/j.bioactmat.2025.08.00810.1016/j.bioactmat.2025.08.008 ↗
68. 10.15212/bioi-2025-012210.15212/bioi-2025-0122 ↗
69. 10.1126/sciadv.abn700610.1126/sciadv.abn7006 ↗